Device Vascular Microcatheter

Sublime Microcatheter, 014, 65cm, Straight

Payments companies reported to CMS as associated with Sublime Microcatheter, 014, 65cm, Straight. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$80Kassociated payments (2023-2025)
129clinicians with associated payments
1company reporting

By year

2023 $80K

Payments reported as associated with Sublime Microcatheter, 014, 65cm, Straight, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $68K
Cardiovascular Disease $6,367
Vascular & Interventional Radiology $2,360
Vascular Surgery $2,093
Family $219
Acute Care (Nurse Practitioner) $217

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sublime Microcatheter, 014, 65cm, Straight

These are the largest totals companies reported as associated with Sublime Microcatheter, 014, 65cm, Straight. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Pradeep Nair Houma, LA Interventional Cardiology $22,077.94
Paul Michael Sebring, FL Interventional Cardiology $12,491.75
Ankur Lodha Lafayette, LA Interventional Cardiology $10,523.25
Robert Minor Billings, MT Interventional Cardiology $9,000.00
Imraan Ansaarie East Palatka, FL Interventional Cardiology $6,532.50
Aaron Kovaleski Lone Tree, CO Vascular & Interventional Radiology $2,250.00
Usman Sheriff Harlingen, TX Cardiovascular Disease $1,925.72
Tariq Siddiqui El Paso, TX Cardiovascular Disease $1,716.29
Nayan Agarwal Saint Augustine, FL Interventional Cardiology $1,601.75
Vijay Doraiswamy Tucson, AZ Interventional Cardiology $1,383.46

Prescribed Sublime Microcatheter, 014, 65cm, Straight?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.